Loading...
Loading...
India's empagliflozin imports from UNITED KINGDOM total $205.1K across 38 shipments from 14 foreign suppliers. ALMAC CLINICAL SERVICES. leads with $147.8K in import value; the top 5 suppliers together control 92.1% of this origin. Leading Indian buyers include GEORGE INSTITUTE SERVICES INDIA PRIVATE LIMITED. This corridor reflects India's pharmaceutical import demand for empagliflozin — a diversified sourcing base with multiple active suppliers from UNITED KINGDOM.

ALMAC CLINICAL SERVICES. is the leading Empagliflozin supplier from UNITED KINGDOM to India, with import value of $147.8K across 1 shipments. The top 5 suppliers — ALMAC CLINICAL SERVICES., ALMAC CLINICAL SERVICES, BILCARE GCS LIMITED, MS CALIGOR OPCO UK LIMITED, CALIGOR OPCO UK LIMITED — collectively account for 92.1% of total import value from this origin.
Ranked by import value (USD) · Indian Customs (DGFT) data
| # | Supplier | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | ALMAC CLINICAL SERVICES. | $147.8K | 1 | 72.1% |
| 2 | ALMAC CLINICAL SERVICES | $26.5K | 1 | 12.9% |
| 3 | BILCARE GCS LIMITED | $6.6K | 6 | 3.2% |
| 4 | MS CALIGOR OPCO UK LIMITED | $4.2K | 2 | 2.1% |
| 5 | CALIGOR OPCO UK LIMITED | $3.7K | 2 | 1.8% |
| 6 | NEWLIFE BIOPHARMA LTD | $3.3K | 2 | 1.6% |
| 7 | MSCLINIGEN HEALTHCARE LIMITED | $3.1K | 1 | 1.5% |
| 8 | E-PHARM LIMITED | $2.7K | 10 | 1.3% |
| 9 | E-PHARMA LIMITED | $2.7K | 2 | 1.3% |
| 10 | M/S. CLINIGEN HEALTHCARE LTD. | $2.4K | 2 | 1.2% |
| 11 | SIGMA PHARMACEUTICALS PLC | $963 | 1 | 0.5% |
| 12 | E PHARM LIMITED | $888 | 3 | 0.4% |
| 13 | CALIGOR OPCO LLC | $267 | 4 | 0.1% |
| 14 | SYRI LIMITED T/A THAME LABS B&S GROUP | $36 | 1 | 0.0% |
Ranked by import value (USD)
| # | Buyer | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | GEORGE INSTITUTE SERVICES INDIA PRIVATE LIMITED | $147.8K | 1 | 72.1% |
| 2 | IQVIA RDS (INDIA) PRIVATE LIMITED | $26.5K | 1 | 12.9% |
| 3 | SANDOZ PRIVATE LIMITED | $11.0K | 5 | 5.4% |
| 4 | MICRO LABS LIMITED | $6.6K | 6 | 3.2% |
| 5 | FDC LIMITED | $3.3K | 2 | 1.6% |
| 6 | LUPIN LIMITED | $2.7K | 2 | 1.3% |
| 7 | NOVARTIS HEALTHCARE PRIVATE LIMITED | $2.4K | 2 | 1.2% |
| 8 | MSN LABORATORIES PRIVATE LIMITED | $1.5K | 2 | 0.7% |
| 9 | DR.REDDY'S LABORATORIES LTD | $1.2K | 2 | 0.6% |
| 10 | KOPRAN LIMITED | $963 | 1 | 0.5% |
| 11 | QPS BIOSERVE INDIA PRIVATE LIMITED | $855 | 1 | 0.4% |
| 12 | AURIGENE PHARMACEUTICAL SERVICES LIMITED | $267 | 4 | 0.1% |
| 13 | GOWRIE RESEARCH PRIVATE LIMITED | $36 | 1 | 0.0% |
| 14 | GRANULES INDIA LIMITED | $33 | 8 | 0.0% |
Answers based on Indian Customs (DGFT) import records compiled by TransData Nexus
The top Empagliflozin suppliers from UNITED KINGDOM to India include ALMAC CLINICAL SERVICES., ALMAC CLINICAL SERVICES, BILCARE GCS LIMITED. The leading supplier is ALMAC CLINICAL SERVICES. with import value of $147.8K USD across 1 shipments. India imported Empagliflozin worth $205.1K USD from UNITED KINGDOM in total across 38 shipments.
India imported Empagliflozin worth $205.1K USD from UNITED KINGDOM across 38 shipments. Data is from Indian Customs (DGFT) records. Values are in USD.
The main Indian buyers of Empagliflozin sourced from UNITED KINGDOM include GEORGE INSTITUTE SERVICES INDIA PRIVATE LIMITED, IQVIA RDS (INDIA) PRIVATE LIMITED, SANDOZ PRIVATE LIMITED. The largest buyer is GEORGE INSTITUTE SERVICES INDIA PRIVATE LIMITED with $147.8K in imports across 1 shipments.
The total value of Empagliflozin imports from UNITED KINGDOM to India is $205.1K USD, across 38 shipments and 14 foreign suppliers. Data source: Indian Customs (DGFT).
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
38 Verified Shipments
14 suppliers, 14 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists